FBR


FBR Capital Maintains Market Perform on LendingClub Corp Ahead of Upcoming Annual Shareholder Meeting

With LendingClub Corp (NYSE:LC) preparing to its annual shareholder meeting on June 28, FBR analyst Bob Ramsey weighs in with a few insights. The analyst maintained a …

FBR Remains Positive on FuelCell Energy Inc (FCEL) Following Weak F2Q16 Results

In a research report released today, FBR analyst Carter Driscoll reiterated an Outperform rating on shares of FuelCell Energy Inc (NASDAQ:FCEL), with a price …

Biotech Beat: FBR Analysts Weigh In on Galena Biopharma Inc (GALE), Peregrine Pharmaceuticals (PPHM) and Immune Pharmaceuticals Inc (IMNP)

Galena Biopharma Inc FBR analyst Vernon Bernardino weighs in on Galena Biopharma Inc (NASDAQ:GALE), after the biotech company announced that the FDA has given Fast …

Analysts Pound the Table on Apple Inc. (AAPL) and Stratasys, Ltd. (SSYS)

Analysts were out pounding the table on tech giant Apple Inc. (NASDAQ:AAPL) and 3D printing firm Stratasys, Ltd.

FBR Reiterates Outperform on Peregrine Pharmaceuticals (PPHM) Ahead of ASCO 2016 Annual Meeting

In a research report issued Friday, FBR analyst Thomas Yip reiterated an Outperform rating on shares of Peregrine Pharmaceuticals (NASDAQ:PPHM), with a $1.00 price target, …

FBR Reiterates Outperform Rating On CytRx Corporation (CYTR) Following Release Of ASCO Abstracts

In a research report released Friday, FBR analyst Christopher James reiterated an Outperform rating on shares of CytRx Corporation (NASDAQ:CYTR), with an $8 price …

Analysts Weigh In On Two Volatile Stocks: Halcon Resources Corp (HK) and American Eagle Outfitters (AEO)

Halcon Resources Corp Today has been nothing short of a nightmare for shareholders of oil and gas Halcon Resources Corp (NYSE:HK). Shares of …

Sell-Side Analysts Weigh In on Two Small Cap Biotechs: Advaxis, Inc. (ADXS) and Keryx Biopharmaceuticals (KERX)

Healthcare analysts at sell-side firms FBR and Brean Capital were out today with some commentary on small-cap biotech companies Advaxis, Inc. (NASDAQ:ADXS) and Keryx Biopharmaceuticals (NASDAQ:KERX).

Analysts Weigh In On Two Raising Stocks: Synthetic Biologics Inc (SYN) and Yelp Inc (YELP)

Synthetic Biologics Inc Synthetic Biologics Inc (NYSE:SYN) shareholders are celebrating today after the biotech company reported above-consensus first-quarter results, sending shares up 23%. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts